Pregled bibliografske jedinice broj: 1080225
Novel meta N-aryl substituted 3-hydroxypyridin- 4-ones and their adamantyl derivatives
Novel meta N-aryl substituted 3-hydroxypyridin- 4-ones and their adamantyl derivatives // 18. Ružičkini dani : Knjiga sažetaka / Jukić, Ante (ur.).
Zagreb: Hrvatsko društvo kemijskih inženjera i tehnologa (HDKI) ; Prehrambeno tehnološki fakultet Sveučilišta Josipa Jurja Strossmayera u Osijeku, 2020. str. 130-130 (poster, domaća recenzija, sažetak, ostalo)
CROSBI ID: 1080225 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Novel meta N-aryl substituted 3-hydroxypyridin-
4-ones
and their adamantyl derivatives
Autori
Dandić, Andrea ; Car, Željka ; Petrović Peroković, Vesna
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, ostalo
Izvornik
18. Ružičkini dani : Knjiga sažetaka
/ Jukić, Ante - Zagreb : Hrvatsko društvo kemijskih inženjera i tehnologa (HDKI) ; Prehrambeno tehnološki fakultet Sveučilišta Josipa Jurja Strossmayera u Osijeku, 2020, 130-130
ISBN
978-953-6894-75-8
Skup
18. Ružičkini dani "Danas znanost - sutra industrija"
Mjesto i datum
Vukovar, Hrvatska, 16.09.2020. - 18.09.2020
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
adamantan-1-ylacetic acid, antitumor activity, 3-hydroxypyridin-4-ones,
Sažetak
3-Hydroxypyridin-4-ones are a well known class of heterocyclic compounds extensively studied due to their broad spectrum of biological activities (antibacterial, antidiabetes, antiprotozoal, antineurodegenerative and anticancer).[1] In our previous work we investigated several para N-aryl substituted 3- hydroxy-2-methylpyridin-4-ones as well as their ester adamantyl derivatives for their in vitro antitumor properties. All tested compounds showed antiproliferative activity ranging from moderate to strong on all inspected cell lines with lipophilic adamantane containing derivatives being active at low micromolar IC50 concentrations.[2] In the continuation of our work novel lipophilic adamantyl derivatives of meta N- aryl substituted 3-hydroxy-2- methylpyridin-4-ones were prepared with the aim of evaluating their in vitro antitumor properties on the panel of cancer cell lines. The compounds were synthesized starting from corresponding pyridinones, which are prepared first in an autoclave, and subsequently acylated with adamantan-1-ylacetic acid. Further structure-activity relationship study (SAR) of such and similar pyridinone derivatives as potential anticancer agents is now in progress. Antitumor properties of novel compounds started to elucidate the key elements, primarily the nature and position of the substituent on the aryl part on the adamantyl pyridinones, needed for their high antiproliferative activity. Keywords: adamantan-1-ylacetic acid, antitumor activity, 3- hydroxypyridin-4-ones, [1] M.A. Santos, S. Chaves, Future Med. Chem. 7 (2015) 383-410. [2] V. Petrović Peroković, Ž. Car, T. Opačak- Bernardi, I. Martin-Kleiner, M. Kralj, S. Tomić, Mol. Div. 21 (2017) 881-891.
Izvorni jezik
Engleski
Znanstvena područja
Kemija
POVEZANOST RADA
Ustanove:
Prirodoslovno-matematički fakultet, Zagreb,
Sveučilište u Osijeku - Odjel za kemiju